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A Multicenter Review of Carotid Body Tumour Management*
M.S. Sajid, G. Hamilton and D.M. Baker* on behalf of Joint Vascular Research Group
Vascular Unit, Department of Surgery, Royal Free Hospital, Pond Street,
Hampstead, London NW3 2QG, UK
Objective. Carotid body tumour (CBT) is a rare but the most common form of head and neck paraganglioma (PGL). We
present the biggest ever series on CBT in UK/EU discussing diagnostic challenges, surgical treatment and complications of
surgical intervention.
Method. A detailed proforma was designed and sent to all members of Joint Vascular Reasearch Group (JVRG). Data of
95 patients was collected. Generic terms including carotid body tumour/s, or paraganglioma/s were used to search a variety
of electronic database in order to get latest informations available in literature.
Results. A total of 95 patients were recorded in our data from 1979 to 2005. Mean age of presentation was 55 years.
Incidence was higher in females. CBT was more common on right side (58%). 18% tumours were bilateral. Neck lump
(98%) and pressure symptoms including cranial nerve deficits and pain were main presenting complaints. About 18%
of tumours were familial. Only 4.2% were malignant. Duplex scan is the best investigation for diagnosis, though MRI,
DSA and CT scan are important for preoperative assessment. Surgery is the treatment of choice. Stroke and cranial nerve
injury constitute postoperative morbidity (35%) and mortality (1%). Incidence of postoperative cranial nerve deficit was
about 19%. Combined ipsilateral and contralateral recurrence rate was 4.2%.
Conclusion. CBT is a rare condition which needs surgical excision by experienced vascular surgeon. Surgical resection is
associated with significant morbidity of 35% and mortality of 1%. Mostly CBT is benign but malignant forms are not
uncommon.
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Although the most common form of head and neck
paraganglioma, Carotid body tumours (CBT) remain
rare and most vascular surgeons will encounter only
a very few during their career. Publications on CBT
management tend to arise from single centre studies.1
In an attempt to determine more accurately the modes
of presentation, investigation and treatment as well as
outcome across a broader spectrum of surgeons, the
retrospective experience of the 33 vascular units of
the Joint Vascular Research group (JVRG) over several
years has been pooled. . The Joint vascular research
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Methods
A detailed proforma was designed and ethical
committee approval gained to retrospectively review
patient notes . This questionnaire included demo-
graphic details of patient, possible symptomatolgy, di-
agnostic techniques used, type of treatment provided,
type of surgeon involved, post surgery complications,
recurrence rate and follow up methodology. This
questionnaire was emailed to all members of JVRG.
Data from a JVRG member from Netherlands was
also included.
A literature search was also undertaken in order to
compare our data with others. Studies or case reports
published between January 1970 and September 2005
were identified through the MEDLINE, EMBASE,rved.
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a search in all languages, through review of Current
Contents. Generic terms carotid body tumour, carotid
paraganglioma, head and neck paraganglioma, chemo-
dectoma and glomus tumour were used to search
the electronic database. Hand searching and looking
through references quoted in useful articles were
also carried out and yielded few more articles.
Results
11 vascular units did not have any experience of CBT
management. 10 major vascular centres (Table 1) had
treated these tumours and submitted proformas. 12
members did not submit data. So overall this data rep-
resents the experience of 21 out of 33 vascular units
(68%). The data of 95 patients of CBT was reviewed
to generate summative outcome. We assume that
only vascular units with a fair number of cases and
with better results submitted their data for combined
analysis, therefore the quality of the results we are
presenting may be biased by the selection criteria.
The Mean age at presentation was 55 years but it var-
ied from 18e94 years. The male to female ratio was
1: 1.9 (63:32). 55 (57%) tumours were found on right
side, 24 (25%) on left side and 16 (17%) were bilateral.
In patients where there was a family history (16) of
CBTs, 4 tumours had had previous surgery and
were considered recurrences. The dimensions and
grade of each tumour (i.e. relationship and involve-
ment of the carotid arterial/jugular venous system)
was difficult to assess due to insufficient data and
lack of common consensus on classification system
of Shamblin. In this series only one tumour was func-
tional and one was associated with paraganglioma
else where, 4 (4.2%) were found to be malignant There
was no consensus on the definition of malignant
CBT among the members of JVRG but all tumours
which were locally invasive and with the evidence of
Table 1. Participating JVRG members
No Trust/Hospital name Number
of cases
1 Royal Free Hospital London 7
2 St Mary Hospital London 36
3 Mr Hero Van Urk (Rotterdam, Holland) 17
4 Nottingham 3
5 Royal Cornwall Hospitals 4
6 Norfolk and Norwich University Hospital 10
7 Freeman Hospital Newcastle 9
8 South Tees Hospital Middlesbrough 1
9 Birmingham Heartlands Hospitals 1
10 Royal Bournemouth 7
Total 95
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Shamblin classification system was not used for every
case in all vascular units and detailed information
about this classification was not available in patient’s
history notes. That is why we could not analyze our
data to assess the outcome according to Shamblin
classification of CBT. The exact cause of higher female
preponderance is unknown but possibly hormonal
changes due to menstruation and pregnancy might
well be a factor.
Almost all tumours presented as a neck lump with
or without pressure symptoms like neck pain, dys-
phonia, hoarseness, stridor, dysphagia, odynophagia,
cranial nerve palsy, jaw stiffness and sore throat .
About 22% of patients presented with cranial nerve
deficit. The functioning (Fig. 1). CBT which was asso-
ciated with a pheochromocytoma (1) presented with
palpitations, tachycardia and hypertension.
Duplex ultrasound scanning was considered pri-
mary diagnostic investigation among JVRG members.
It depicts growth at carotid bifurcation causing splay-
ing and helps to define hypervascularity of growth.
Angiography (DSA), CT, CTA, MRI and MRA were
used for preoperative assessment (Fig. 2). DSA was
not used very often (only 20%) by JVRG members
for the diagnosis of CBT or preoperative assessment.
Surgical resection of CBT was offered to all pa-
tients, though only one patient had preoperative radio-
therapy for tumour destaging. Surgery was performed
by specialist vascular surgeon alone (80%) or by ENT
and vascular surgeon together (20%).
Surgical resection of CBT was associated with 1%
mortality and 33% morbidity. Cranial nerve damage,
stroke, TIA, wound haematoma; cutaneous nerve in-
jury and Horner syndrome were main complications
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Fig. 1. Presentation of CBT.
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deficit on first post-operative day was 19%, which re-
duced to 3% after 6 months and less than 1% at mean
follow-up. There was only one case of permanent
cranial nerve damage (hoarseness of voice due to
vagus nerve injury; 1%) where tumour size was 20 cm,
malignant in nature and it was of type IV according to
Shamblin classification.
About 95.8% of tumours were benign and 4.2%
were malignant. Combined ipsilateral and contralat-
eral recurrence rate was 4.2%. There was no fixed pro-
tocol for follow up in any of JVRG centre. Average
follow up time was one year. Since this retrospective
analysis encompasses 95 patients of CBT over a time
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Fig. 2. Investigations used for CBT diagnosis.
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Fig. 3. Complications of CBT surgery.period of 26 years, with mean follow up time of one
year only, it is very difficult to explain the exact recur-
rence rate. There were 17 patients who lost follow-up
and several more cases without follow-up record.
Therefore, there is a strong possibility of sample con-
tamination and biased record of CBT patients. Based
on this fact, the recurrence rate in our data may be
of limited value and same applies on follow-up data.
Since the experience of the management of CBT in
different vascular centres of JVRG varies greatly (from
1 patient to 36 patients), it was difficult to compare
and contrast the outcome of these units.
Discussion
CBTs are invariably benign but malignant forms are
seen occasionally. Like other paragangliomas, CBT
originates from cells which develop from neural crest.
CBT is a non functioning tumour but sometimes his-
tamine, serotonin, epinephrine and norepinephrine
secreting tumours are also seen. Incidence of CBT is
about 1 in 30,000. There are 3 distinct types; familial,
sporadic and hyperplastic forms. Hyperplastic type is
very common in patients of COPD, patients of congen-
ital cyanotic heart disease and in the areas which are
more than 5000 feet above sea level like New Mexico,
Peru and Colorado. Chronic exposure to hypoxia is re-
sponsible for higher incidence of hyperplastic CBT in
these patients. Familial type mainly involved younger
patients, usually associated with head and neck para-
gangliomas and was more likely to be malignant.
Von Haller first described the carotid body in 1743.
In 1762, Heller introduced the term glomus tumour
and this was re-established by Gild in 1953. Reigner
attempted excision of a CBT in 1880, but the patient
died. Maydl also attempted CBT excision in 1886 but
the patient developed a stroke. The first successful
CBT excision was performed by Albert in 1889.
Kohn first introduced the term paraganglioma (PGL)
in 1903. Based on the work of Glenner and Grimley
the term paraganglioma is now the most widely
used to classify CBT.2
As mentioned before surgical resection is the only
treatment of choice for CBT, though preoperative
chemo-embolization and radiotherapy have been
mentioned in literature. Surgical resection is not risk
free and it is associated with significant morbidity
and mortality.3 The Shamblin’s classification has
been widely used for risk stratification before surgical
intervention. According to this classification , bigger is
the CBT, higher is the risk of cranial nerve injury
and vascular injury. If the size of CBT is more than
5 cm, mortality is 1%e3% after surgical intervention.3
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system and need for modified Shamblin’s classifica-
tion has been suggested in literature.3 Whenever there
is need for vascular reconstruction during resection of
CBT, the risk of cranial nerve injury increases dramat-
ically. This neurological deficit is more likely related
to locally advanced tumour and pathology of the
tumour rather than surgical technique.4
Mini Literature Review (Table 2)
Surgery is the only treatment of choice for CBT. There
is very little if any role of embolization or radiother-
apy in the management of CBT. On mini literature re-
view, outcome of surgical intervention in JVRG series
is comparable to international data. We compared our
three parameters; cranial nerve injury rate, stroke rate
and mortality rate with international studies on CBT
management.
Luna-Ortiz et al. recently published an article quot-
ing 49% incidence of cranial nerve deficit after CBTex-
cision as compared to 19% in our article. However in
literature the incidence of cranial nerve deficit after
CBT surgery varies from 11% to 49%. Most of these
cranial nerve injuries are temporary. The incidence
of permanent cranial nerve deficit has been quoted
less than 1% in international literature and it is
comparable with JVRG data.
TIA/ Stroke rate after CBT excision varies from
0 to 8% in international studies while in our study it
is 1%. Torres et al. published data of 96 patients of
CBT and the incidence of TIA/Stroke after surgical in-
tervention was 0% indicating a great variation in this
complication. The difference about the incidence of
TIA/Stroke among different publications may be
due to experience of operating surgeon. Yang et al.
published data of 27 patients and mortality in this
series was 7.4% while it varies from 0e7.4% in inter-
national literature. Mortality in JVRG series was
only 1%.
Table 2. Mini-literature Review
Studies (CBT
surgery)
Patients Cranial
palsy
Stroke Mortality
Luna-Ortiz et al.5 46 49% 0 1.5%
Patetsios et al.6 29 17% 0 3%
Dardik et al.7 25 33% 4% 0
Huang et al.8 30 36% 0 0
Plukker et al.9 35 11% 8% 0
Wang et al.10 29 41% 0 0
Westerband et al.11 31 19% 0 0
Torres et al.12 96 23% 0 1%
Yang et al.13 27 30% 2% 7.4%
Gaylis et al.14 44 18% 2.5% 4.5%
Dickinson et al.15 32 19% 4% 0
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 Carotid body tumours are rare, but they are still the
commonest of the head and neck paraganglioms.
 There are distinct hyperplastic, sporadic and
familial forms.
 Duplex scan is effective in making the diagnosis,
but angiography and CT or MRI is helpful to
plan surgery.
 Excision is indicated for most tumours, but the
surgery is not risk free and the best results are
achieved by specialist team.
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